On May 10, 2022 Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS reported preliminary financial results for the first quarter ended March 31, 2022 (Press release, Celsius Therapeutics, MAY 10, 2022, View Source [SID1234614146]). Management will host a conference call today at 4:30 p.m. Eastern Time to discuss the results with the investment community.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A PDF containing our first quarter 2022 results and full financial tables is available at:
View Source

To participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:

Webcast: View Source

An audio replay of the call will be available on the Company’s website at:
View Source